Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Study - Use of Gelronate Gel vs. Aloevera in Preventing/Minimizing Radiation-induced Dermatitis in Breast Cancer Patients

NCT03941665 is registered in ClinicalTrials.gov with Sheba Medical Center as lead sponsor.

NCT NCT03941665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03941665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Study - Use of Gelronate Gel vs. Aloevera in Preventing/Minimizing Radiation-induced Dermatitis in Breast Cancer Patients
Lead sponsor
Sheba Medical Center
Phase
Not applicable
Overall status
Completed
Start date
March 25, 2019
Completion date
May 3, 2020
Enrollment
136 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radiation dermatitis